• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美国三个城市中,阿片类药物使用者中丁丙诺啡的替代用途。

Alternative use of buprenorphine among people who use opioids in three U.S. Cities.

机构信息

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Subst Abus. 2022;43(1):364-370. doi: 10.1080/08897077.2021.1942395. Epub 2021 Jul 2.

DOI:10.1080/08897077.2021.1942395
PMID:34214403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11216848/
Abstract

: Buprenorphine is an effective treatment for opioid use disorder, yet some persons are concerned with its "alternative use" (i.e., any use unintended by the prescriber). There is limited evidence on the factors associated with alternative use of buprenorphine (AUB); in this study, we examined correlates of recent (past 6 months) AUB. : Multivariable logistic regression was used to analyze survey data from a multi-site, cross-sectional study of people who use drugs (PWUD) ( = 334) in Baltimore, Maryland; Boston, Massachusetts; and Providence, Rhode Island. : One-fifth (20%) of the sample reported recent AUB. In adjusted analyses, significant negative correlates of AUB were female gender (adjusted odds ratio [aOR] 0.48, 95% confidence intervals [CI] 0.24-0.95), recent emergency room visit (aOR 0.45, 95% CI 0.23-0.89), and recent injection drug use (aOR 0.41, 95% CI 0.19-0.88). Significant positive correlates were alternative use of other prescription opioids (aOR 8.32, 95% CI 4.22-16.38), three or more overdoses in the past year (aOR 3.74, 95% CI 1.53-9.17), recent buprenorphine use as prescribed (aOR 2.50, 95% CI 1.12-5.55), and recent residential rehabilitation treatment (aOR 3.71, 95% CI 1.50-9.16). : Structural and behavioral correlates of AUB may help identify PWUD at high risk of overdose with unmet treatment needs.

摘要

丁丙诺啡是一种治疗阿片类药物使用障碍的有效药物,但有些人担心其“非医疗用途”(即任何非处方预期的用途)。关于丁丙诺啡非医疗用途(AUB)的相关因素的证据有限;在这项研究中,我们研究了与丁丙诺啡近期 AUB 相关的因素。

我们使用多变量逻辑回归分析了马里兰州巴尔的摩、马萨诸塞州波士顿和罗得岛州普罗维登斯三地多地点横断面研究中药物使用者(PWUD)(n=334)的调查数据。

该样本中有五分之一(20%)的人报告了近期 AUB。在调整后的分析中,AUB 的显著负相关因素为女性性别(调整后的优势比 [aOR] 0.48,95%置信区间 [CI] 0.24-0.95)、最近急诊就诊(aOR 0.45,95% CI 0.23-0.89)和最近注射吸毒(aOR 0.41,95% CI 0.19-0.88)。显著的正相关因素为其他处方类阿片类药物的替代使用(aOR 8.32,95% CI 4.22-16.38)、过去一年中出现三次或更多次药物过量(aOR 3.74,95% CI 1.53-9.17)、最近按处方使用丁丙诺啡(aOR 2.50,95% CI 1.12-5.55)和最近接受住院康复治疗(aOR 3.71,95% CI 1.50-9.16)。

AUB 的结构性和行为相关因素可能有助于确定那些有药物过量风险且治疗需求未得到满足的药物使用障碍者。

相似文献

1
Alternative use of buprenorphine among people who use opioids in three U.S. Cities.在美国三个城市中,阿片类药物使用者中丁丙诺啡的替代用途。
Subst Abus. 2022;43(1):364-370. doi: 10.1080/08897077.2021.1942395. Epub 2021 Jul 2.
2
Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence.在波士顿、巴尔的摩和普罗维登斯,疑似接触芬太尼的阿片类药物使用者采用的减少危害措施。
Harm Reduct J. 2019 Jun 24;16(1):39. doi: 10.1186/s12954-019-0311-9.
3
Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.乌克兰注射毒品的阿片类药物依赖者中参与阿片类激动剂治疗意愿的决定因素。
Drug Alcohol Depend. 2016 Aug 1;165:213-20. doi: 10.1016/j.drugalcdep.2016.06.011. Epub 2016 Jun 17.
4
Preference for drugs containing fentanyl from a cross-sectional survey of people who use illicit opioids in three United States cities.在美国三个城市使用非法阿片类药物的人群进行的横断面调查显示,人们更喜欢含有芬太尼的药物。
Drug Alcohol Depend. 2019 Nov 1;204:107547. doi: 10.1016/j.drugalcdep.2019.107547. Epub 2019 Aug 23.
5
Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.2017-18 年接受丁丙诺啡治疗的患者中,与纳洛酮处方填写相关的患者、处方医生和社区因素。
Drug Alcohol Depend. 2021 Apr 1;221:108569. doi: 10.1016/j.drugalcdep.2021.108569. Epub 2021 Feb 3.
6
Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence.在美国三个城市(巴尔的摩、波士顿和普罗维登斯)实施基于社区的毒品检测服务对吸毒者的可接受性。
Int J Drug Policy. 2019 Jun;68:46-53. doi: 10.1016/j.drugpo.2019.03.003. Epub 2019 Apr 13.
7
Utilization of buprenorphine and methadone among opioid users who inject drugs.阿片类药物使用者中使用丁丙诺啡和美沙酮的情况。
Subst Abus. 2018 Jan 2;39(1):83-88. doi: 10.1080/08897077.2017.1363844. Epub 2017 Sep 18.
8
Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.在加拿大不列颠哥伦比亚省接受减少伤害服务的人群中,同时使用兴奋剂和阿片类药物的相关因素:2019 年减少伤害客户调查结果。
Int J Drug Policy. 2022 Apr;102:103602. doi: 10.1016/j.drugpo.2022.103602. Epub 2022 Feb 4.
9
Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.接受丁丙诺啡治疗的人群中,处方苯二氮䓬类药物、过量死亡与丁丙诺啡停药之间的关联。
Addiction. 2020 May;115(5):924-932. doi: 10.1111/add.14886. Epub 2020 Jan 20.
10
Sociodemographic and prescribing characteristics that impact long-term retention in buprenorphine treatment for opioid use disorder among a statewide population.影响全州范围内阿片类药物使用障碍患者接受丁丙诺啡治疗长期保留率的社会人口学和处方特征。
Drug Alcohol Depend. 2022 Dec 1;241:109680. doi: 10.1016/j.drugalcdep.2022.109680. Epub 2022 Oct 30.

引用本文的文献

1
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.社区药房中阿片类药物使用障碍治疗扩展的研究重点。
Subst Abus. 2023 Oct;44(4):264-276. doi: 10.1177/08897077231203849. Epub 2023 Oct 30.
2
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use.根据保留定义衡量 HIV 合并阿片类物质使用障碍人群在丁丙诺啡治疗各阶段的时间及其与可卡因和危险饮酒的关系。
Addict Sci Clin Pract. 2023 Sep 2;18(1):51. doi: 10.1186/s13722-023-00408-8.
3
Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.五个医疗系统中急诊室开具丁丙诺啡的种族和民族差异。
Acad Emerg Med. 2023 Jul;30(7):709-720. doi: 10.1111/acem.14668. Epub 2023 Feb 27.

本文引用的文献

1
Institutions For Mental Diseases Medicaid Waivers: Impact On Payments For Substance Use Treatment Facilities.精神疾病医疗补助豁免机构:对物质使用治疗设施支付的影响。
Health Aff (Millwood). 2021 Feb;40(2):326-333. doi: 10.1377/hlthaff.2020.00404.
2
Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19.解决新冠疫情期间阿片类物质使用障碍药物获取方面的种族和社会经济差异问题。
J Subst Abuse Treat. 2021 Mar;122:108214. doi: 10.1016/j.jsat.2020.108214. Epub 2020 Nov 24.
3
Commentary on Jin et al. (2020): Regulatory and allocative policies inform access to opioid agonist therapy.对金等人(2020年)的评论:监管与分配政策影响阿片类激动剂治疗的可及性。
Addiction. 2020 Dec;115(12):2255-2256. doi: 10.1111/add.15190. Epub 2020 Aug 3.
4
Opioid Overdose Deaths with Buprenorphine Detected in Postmortem Toxicology: a Retrospective Analysis.阿片类药物过量死亡与死后毒理学检测到丁丙诺啡:回顾性分析。
J Med Toxicol. 2021 Jan;17(1):10-15. doi: 10.1007/s13181-020-00795-3. Epub 2020 Jul 9.
5
A systematic review of opioid overdose interventions delivered within emergency departments.对急诊科实施的阿片类药物过量干预措施的系统评价。
Drug Alcohol Depend. 2020 Aug 1;213:108009. doi: 10.1016/j.drugalcdep.2020.108009. Epub 2020 May 23.
6
Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?非故意药物过量:非处方丁丙诺啡使用频率增加是否与更低的过量风险相关?
Int J Drug Policy. 2020 Apr 17;79:102722. doi: 10.1016/j.drugpo.2020.102722.
7
How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.使用丁丙诺啡产品的动机与使用阿片类镇痛药的动机有何不同:来自娱乐性使用者互联网讨论的观察性研究证据。
JMIR Public Health Surveill. 2020 Mar 25;6(1):e16038. doi: 10.2196/16038.
8
On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.按自己的条件:非处方丁丙诺啡自我治疗阿片类药物使用障碍的动机。
Drug Alcohol Depend. 2020 May 1;210:107958. doi: 10.1016/j.drugalcdep.2020.107958. Epub 2020 Mar 16.
9
Drug and Opioid-Involved Overdose Deaths - United States, 2017-2018.药物和阿片类药物相关过量死亡 - 美国,2017-2018 年。
MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):290-297. doi: 10.15585/mmwr.mm6911a4.
10
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.在美国全州接受阿片类药物使用障碍服务的人群中,阿片类激动剂治疗与致命性药物过量风险的关系。
Addiction. 2020 Sep;115(9):1683-1694. doi: 10.1111/add.14991. Epub 2020 Feb 24.